The purpose of this study is to analyze whether supplementation of general anesthesia (GA) with thoracic epidural analgesia (TEA) for right lobe donor hepatectomy is a safe modality of pain relief in terms of changes in postoperative coagulation profile, incidence of epidural catheter-related complications, and timing of removal of epidural catheter. Retrospective analysis of the record of 104 patients who received TEA for right lobe donor hepatectomy was done. Platelet count, international normalized ratio, alanine aminotransferase, and aspartate aminotransferase were recorded postoperatively until the removal of the epidural catheter. The day of removal of the epidural catheter and visual analogue scale (VAS) scores were also recorded. Any complication encountered was documented. Intraoperatively, central venous pressure (CVP), hemodynamic variables, and volume of intravenous fluids infused were also noted. Statistical analysis was performed by using SPSS statistical package, version 17.0 (SPSS Inc. Chicago, IL). Continuous variables were presented as mean 6 standard deviation. A total of 90% of patients had mean VAS scores between 1 and 4 in the postoperative period between days 1 and 5. None of the patients had a VAS score above 5. Although changes in coagulation status were encountered in all patients in the postoperative period, these changes were transient and did not persist beyond postoperative day (POD) 5. There was no delay in removal of the epidural catheter, and the majority of patients had the catheter removed by POD 4. There was no incidence of epidural hematoma. Aside from good intraoperative and postoperative analgesia, TEA in combination with balanced GA and fluid restriction enabled maintenance of low CVP and prevention of hepatic congestion. In conclusion, vigilant use of TEA appears to be safe during donor hepatectomy. Living liver donors should not be denied efficient analgesia for the fear of complications.
Because of the scarcity of deceased donors, living liver donation is an important means to treat patients in need of liver transplantation in developing countries. Use of living donor tissue is potentially advantageous because the procedure can be planned appropriately, the recipient can be optimized for the operation, and the ischemia time is usually short. However, it has potential for significant donor morbidity (8.7%-75%) (1) and mortality (0.1%-0.5%). (2) Postoperative pain is an important cause of morbidity in the donor population. The living donor is a healthy individual who has no prior experience of pain associated after major surgery. After reversal of general anesthesia (GA), the patient has the first experience of significant pain. So, the pain threshold of such a patient cannot be compared with any other patient. (3, 4) Pain can be because of subcostal incision, rib retraction, diaphragmatic irritation, or of visceral origin. (5) This can have a significant negative impact on the quality of life of the donor. (6) Thoracic epidural analgesia (TEA) provides efficient intraoperative and postoperative analgesia following donor hepatectomy. However, there is a controversy regarding the safety of TEA in this group of patients because of the risk of coagulopathy and subsequent fear of epidural hematoma.
Abbreviations: ABG, arterial blood gas; ALT, alanine aminotransferase; ASA, American Society of Anaesthesiologists; AST, aspartate aminotransferase; BP, blood pressure; CSF, cerebrospinal fluid; CTRI, Clinical Trials Registry-India; CVP, central venous pressure; DBP, diastolic blood pressure; ERAS, enhanced recovery after surgery; GA, general anesthesia; ICU, intensive care unit; INR, international normalized ratio; IV, intravenous; LA, local anesthetic; PCA, patient-controlled analgesia; PCEA, patient controlled epidural analgesia; PDPH, postdural puncture headache; POD, postoperative day; PONV, postoperative nausea and vomiting; PT, prothrombin time; SBP, systolic blood pressure; TAP, transversus abdominis plane; TEA, thoracic epidural analgesia; VAS, visual analogue scale.
Primary objectives of this study were to evaluate the safety of TEA in terms of changes in postoperative coagulation profile, to record the incidence of epidural catheter-related complications, and to document the time of removal of epidural catheter. Secondary objectives were to evaluate the effect of TEA on blood pressure (BP), central venous pressure (CVP), subsequent blood loss intraoperatively, and quality of analgesia postoperatively.
Patients and Methods
This retrospective study was conducted after approval by the institutional ethics committee and was registered at Clinical Trials Registry-India (CTRI) (2016/ 09/007247). We identified 110 patients who underwent right lobe donor hepatectomy under GA, for a period of 2 years (2013-2014). Right lobe hepatectomy involved segments V-VIII composing 60% of the total liver mass. Those donors whose right lobe of liver composed of more than 60% of total liver mass were not accepted. Out of 110 patients, 6 patients were excluded (4 refused epidural catheter insertion and in 2 patients epidural insertion failed). Therefore, 104 patients were included in the study.
After placement of standard monitoring devices, GA was induced with thiopentone sodium 4-5 mg/kg, and orotracheal intubation was performed following administration of vecuronium bromide (0.1 mg/kg), supplemented with intravenous (IV) fentanyl (1-2 mg/ kg). Anesthesia was maintained using isoflurane with an air/O 2 mixture and an infusion of injection atracurium (0.5 mg/kg/minute) for neuromuscular block.
After induction, an 18-gauge thoracic epidural catheter was inserted between T7 and T10 epidural space using the loss of resistance to air technique. The midline or lateral approach was used as per the preference of the anesthesiologist. The catheter was directed cephalad and advanced 4 cm in the epidural space. A test dose of 3 mL of 1.5% lidocaine hydrochloride with 15-mg adrenaline was injected. Subcutaneous tunneling of the catheter was done followed by secured fixation to prevent its accidental dislodgment. Subsequently, central venous, radial artery, and urinary catheters were inserted.
Before the surgical incision, an initial bolus of 3-5 mL of 0.25% bupivacaine hydrochloride was given. This was followed by continuous epidural infusion of 0.25% bupivacaine hydrochloride at a rate of 3-6 mL/ hour. IV fluid administration was restricted to maintain CVP < 5 cm H 2 O until the completion of dissection. During the transection of the liver, the epidural infusion rate was decreased to 1-2 mL/hour. After transection was completed, IV fluid in liberal amounts was infused to increase CVP to 10-12 cm of water to restore the euvolemic state and ensure proper hemostasis. Before commencement of abdominal closure, epidural infusion was increased to 6-8 mL/hour. Intraoperatively, arterial blood gas (ABG) test was done thrice, 1 as a baseline, 1 during the course of hepatectomy, and the last 1 before extubation. Acidosis or hypocalcemia if documented during surgery was corrected before extubation.
We also recorded the duration of surgery, amount of intraoperative requirement of fluids, and residual liver volume.
The trachea of all the patients was extubated in the operating room. Any evidence of sedation was recorded. After shifting to the liver intensive care unit (ICU), epidural infusion of 0.25% used intraoperatively was replaced by 0.125% bupivacaine hydrochloride and titrated to 6-8 mL/hour for the first 24 hours. Subsequently, a patient controlled epidural analgesia (PCEA) pump comprising of 0.0625% bupivacaine hydrochloride and fentanyl citrate 2.5 mg/mL was installed at the basal rate of 4 mL/hour, PCEA dose of 6 mL, and a lock-out interval of 30 minutes. If the patient complained of nausea and vomiting and did not respond to antiemetics, then fentanyl was omitted from the PCEA pump.
"The Acute Pain Services" team of an anesthesiologist and a nurse visited the patient thrice daily up to 24 hours after epidural catheter removal.
Pain intensity was measured with a visual analogue scale (VAS). VAS of more than >3 was treated by giving a bolus of 5-8 mL of 0.125% bupivacaine. Postoperatively nausea, vomiting, pruritus, any motor or sensory deficit, and headache were noted.
The international normalized ratio (INR), platelet count, alanine aminotransferase (ALT), and aspartate aminotransferase (AST) levels were recorded until the removal of the epidural catheter. The epidural catheter was removed only when the INR < 1.5 and platelet count > 1 310 9 /L. The day of the removal of the catheter was also recorded.
Statistical analysis was performed using the SPSS statistical package, version 17.0 (SPSS Inc., Chicago, IL). Continuous variables are presented as mean 6 standard deviation, and categorical variables are presented as absolute numbers and percentage. Data were checked for normality before statistical analysis.
Continuous variables over time were analyzed by using repeated analysis of variance.
Results
All 104 patients of right lobe donor hepatectomies were of American Society of Anaesthesiologists (ASA) I and II class. The minimum age of the donor was 18 years and the maximum age was 64 years. The duration of the surgery varied from 6 to 14 hours.
A thoracic epidural catheter was inserted at T7-T8 level in 36.5% of patients, T8-T9 level in 34.6% of patients, and T9-T10 level in 28.9% of patients. The mean depth of insertion of the catheter in epidural space was 3.8 6 0.6 cm. None of the donors had a mean residual volume of liver below 39.3% 6 4.0%.
Postoperatively, the liver enzymes were highest on postoperative day (POD) 1 and normalized by day 5 (Figs. 1 and 2). INR was highest on day 2 ( Fig. 3 ) and dropped to normal by day 5, whereas platelet count was lowest on day 3 and subsequently normalized by day 5 (Fig. 4) . None of the donors had a platelet count less than 66,000/cu mm. In 2 patients, epidural catheters were removed on day 1 itself because of the leakage, and in the 5 patients, it was removed on day 2. At our center, it is a routine practice to provide the patient with the benefit of epidural analgesia for at least 2 days following surgery. In 5 patients, the epidural catheter was removed on POD 2 to facilitate early discharge. In the majority of the patients, the epidural catheter was removed between day 3 and day 5. No patient had the epidural removed after day 6 (Table 1) .
Catheter removal on day 1 and day 2 was done after ensuring normal platelet values and INR. Intraoperative mean, systolic, diastolic pressure; CVP; and volume of IV fluids transfused are shown in Table 2 .
Ninety percent of patients had a mean VAS score of 1-4 in the postoperative period between day 1 and day 5, whereas no case had VAS score above 5 (Table 3) . Those patients who had VAS score > 4 had an epidural catheter placed below T9 and required a bolus of 0.125% bupivacaine and occasionally IV injection of tramadol (50 mg) for breakthrough pain.
Nausea and vomiting were the most frequently encountered complications managed by combination therapy with IV ondansetron and dexamethasone. One patient had headache, which was managed conservatively. One patient had hypotension (mean BP < 60 mm Hg), which was managed by fluid and vasopressors. None of the patients had any longterm neurological sequelae. There was no case of epidural hematoma or sepsis (Table 4 ).
Discussion
Thoracic epidural in patients undergoing right lobe donor hepatectomy provides effective perioperative analgesia. Healthy donors have a very low threshold for pain. Right lobe donor hepatectomy patients have significantly more intense pain than those undergoing major hepatic resection of a tumor. (7) Effective pain relief facilitates early extubation of these patients, and therefore, the use of IV narcotics can be avoided in these patients because their hepatic metabolic ability stands compromised after the surgery.
We did not administer any systemic opioids during the first 24 hours after surgery. The PCEA pump was installed after the first 24 hours. The requirement of rescue analgesia in the form of a bolus of 0.125% bupvicaine and IV tramadol was more in the first 24 hours. Postoperative consumption of local anesthetic (LA) and opioids was at a maximum on the day of installation of the patient-controlled analgesia (PCA) pump, when patients demanded on an average approximately 15-20 PCEA demand doses in 24 hours in addition to the basal infusion of 4 mL/hour. Subsequently, the consumption of LA and narcotics decreased to approximately 5-10 demand doses per 24 hours. These were taken usually before ambulation or dressing. In a retrospective study of 216 patients undergoing living donor hepatectomy, Clarke et al. compared acute postoperative pain intensity between patients who received IV PCA and PCEA. They found that for the first 3 PODs, pain intensity and sedation were significantly lower in patients who received epidural analgesia. (8) However, Yong et al. found no difference in the intensity of postoperative pain between those receiving epidural analgesia and IV PCA. (9) A study by Mondor et al. reported that the use of PCEA for primary pain relief after liver resection reduces the amount of systemic opioids by 50%. (10) It also facilitates early mobilization with a significant reduction in pulmonary and cardiovascular morbidity in the early postoperative period. (11) For living donor hepatectomy, a right subcostal incision with a midline extension to the xiphoid process was given. Because a subcostal incision is associated with significant postoperative pain, adequate analgesia is more likely to be achieved through a thoracic epidural. NOTE: Data are given as n (%). Subcostal transversus abdominis plane (TAP) blocks as a part of a multimodal analgesia technique may be more beneficial for upper midline incisions, but the efficacy of the block wanes as the transverse incision extends beyond the anterior axillary line. (12) A quality block as provided by TEA can provide analgesia for any incision in the upper abdomen, even those extending to the xiphoid. (13) In 1 study, a comparison of a subcostal TAP block supplemented with paracetamol and tramadol was made with epidural analgesia for upper abdominal surgery. Although the pain score was similar in both groups, the TAP group required more rescue analgesia. (14) Therefore, for subcostal incisions, TEA has a significant role for the prevention of incision pain-related morbidity. TEA decreases morbidity following abdominal surgery (6) and provides better dynamic pain relief (15) as is seen in our retrospective analysis. A painful experience of a donor could have detrimental effects on the future propagation of a living donor program.
A thoracic epidural catheter was inserted between T7 and T9 in the majority of our patients. The mean CVP recorded was 5.8 6 1.8 cm H 2 O. The mean systolic and diastolic pressures were 110 6 6.7 and 63.8 6 5.1 mm Hg, respectively. None of the patients required blood transfusion suggesting that vasodilation induced by sympathetic block in combination with balanced GA and restrictive fluid therapy may be useful for maintaining low CVP during hepatic transection. This results in reduced blood loss and transfusion requirements. The same finding was also confirmed by Gurusamy et al. (16) Diuretics and vasodilators were not required to lower CVP and BP in any of the patients. Feltracco et al. (17) also confirmed that TEA in donors has an important role in lowering of CVP and decreasing surgical blood loss. TEA complicates perioperative fluid administration, as was remarked by Page et al. (18) However, this was not seen in our study because we titrated the infusion rate so that the density of the block was maximal prior to incision and prior to extubation and relatively lower during the dissection phase. The dissection phase is the time when there is maximal blood loss. During this period, the combined effect of GA, fluid restriction, and a well-established sympathetic block have already decreased the CVP to a very low level. The blood loss further decreases CVP, so the requirement of epidural infusion is less. Hence, the epidural infusion rate is decreased to prevent any further fall in BP. (17) The analgesic requirement under GA is also lower for dull visceral abdominal pain as compared with superficial and deep somatic abdominal pain. (19) Kim et al. reported that a long duration of anesthesia, low body mass index, and small remnant liver volumes are risk factors for postoperative coagulopathy. (20) Although mean duration of anesthesia in this study was 10 hours, the blood loss was less (500-1200 mL) probably because of refined surgical skills, low CVP, and the use of equipment like Cavitron ultrasonic aspirator to dissect liver parenchyma. The goal-directed intraoperative volume replacement prevented dilutional coagulopathy. In addition, intraoperative acidosis, hypocalcemia, and hypothermia were corrected. The majority of studies recommend placement of a thoracic epidural catheter before induction because of concerns for spinal cord injury. We placed it after induction and did not encounter any complication including spinal cord injury.
A number of complications have been reported with TEA, with frequent ones including hypotension, postoperative nausea and vomiting (PONV), pruritus, postoperative urinary retention, (21) and rare ones being spinal hematoma (1:150,000), adhesive arachnoiditis (0.008%-0.01%), subdural injection (0.01%-0.08%), and neurological injuries (0.006%-0.02%). (22) The most frequent complication that we noticed was nausea and vomiting, which were immediately managed by antiemetics and occasionally by omitting opioids from PCEA pumps.
We did not encounter any case of spinal hematoma or epidural abscess. A single case of postdural puncture headache (PDPH) occurred probably due to migration of the catheter on POD 4. It was a rare to have an instance of intrathecal migration with a previously functioning epidural catheter. The patient had unexplained hypotension and bradycardia on POD 3. The epidural infusion was stopped, and the catheter was aspirated. The aspirate was clear fluid confirmed to be cerebrospinal fluid (CSF) on laboratory analysis. The catheter was removed and subsequent PDPH was successfully managed conservatively. After shifting to ICU, 1 patient had an episode of hypotension. This was probably because of a bolus injection of 8 mL, 0.125% bupivacaine in the epidural space for management of severe pain.
Transient lower limb paresthesias occurred in 2 patients, which were managed by stopping the basal rate of epidural infusion and allowing only the PCA doses. Even though we kept both arms by the side of the patient, 1 patient had transient brachial neuropraxia probably because of compression of the brachial plexus due to rib retraction by abdominal retractors.
Alterations in coagulation profile occurred in all the patients in the postoperative period. This manifested by an increase in prothrombin time (PT; maximum increase on day 2), fall in platelets (minimum level on day 3), and elevated liver enzymes (maximum level on day 1). The alteration in coagulation profile was transient and did not last for more than 5 days after surgery. A number of studies have reported hypocoagulation following donor hepatectomy (23) (24) (25) (26) and have confirmed the transient nature of these changes. In a retrospective study of 141 patients undergoing liver resection, Elterman and Xiong (27) observed that a decrease in platelet count occurred on POD 3, peak PT on POD 2, and epidural catheter was removed between PODs 4 and 5. No evidence of epidural hematoma was observed in any patient. They concluded that epidural analgesia may be safely used in patients undergoing major hepatic resection provided adequate precautions are taken at the time of insertion and removal of epidural catheter.
The optimal timing of removal of the epidural catheter, based on our observations, is POD 4. No patient in this study had an epidural catheter beyond 6 days, and none of the patients required a fresh frozen plasma transfusion prior to epidural catheter removal.
Stamenkovic et al. (28) and Karna (29) reported similar results and suggested that the optimal time of removal of the epidural catheter was POD 5 and Choi et al. (24) reported it as POD 4.
The epidural catheters were removed by the "Acute Pain Services" team only after ensuring PT < 1.5 and a platelet count > 100,000 cells/mm 3 . To date, there is no reported case of spinal hematoma following elective hepatectomy supplemented with TEA. There was no case of accidental removal of the epidural catheter because we did subcutaneous tunneling of the catheter. Therefore, careful use of TEA is safe if regular monitoring is done in the postoperative period up to at least 4-5 days after surgery, and the catheter is removed only after normalization of the coagulation profile which according to our observations is usually by POD 4.
The main limitation of our study is the retrospective nature of the analysis of the data collected. A comparative analysis with patients receiving IV PCA would have been more desirable. However, very few patients were given IV PCA, so a comparison was not feasible.
Are the alternatives to TEA more efficient and safe? IV analgesia with narcotics cannot provide pain relief that is comparable to epidural analgesia and there are also concerns like sedation and postoperative respiratory depression. (30, 31) Epidural analgesia has been shown to provide better pain relief especially during movement in the initial postoperative period following open abdominal surgery when compared with IV PCA. (32, 33) Alternative strategies for pain relief include combining IV PCA with intrathecal morphine. Intrathecal opioids as an alternative for perioperative analgesia was studied by Ko et al., (34) De Pietri et al., (35) and Sakowska et al. (36) They found it effective but reported a risk of pruritus and respiratory depression. Revie et al. in a retrospective study compared TEA with a combination of IV PCA and continuous wound infiltration for patients undergoing liver resection. (37) However, they concluded that a well-functioning TEA was better in terms of analgesic efficacy. Alternatives to TEA in the form of continuous IV bupivacaine 0.25% through catheter in rectus sheath, (38) subcostal TAP blocks, (39) and right thoracic paravertebral block (40) along with IV opioids have been investigated as a part of a multimodal analgesic regimen. To supplement IV analgesia, drugs like ketorolac, (41) dexmedetomidine, gabapentin, (42) and parecoxib (43) have been studied for an opioid-sparing effect. However, there are no systematic reviews to establish their safety and efficacy in liver donors. Further studies are required to compare their analgesic efficacy to TEA in living liver donors.
TEA is often advocated as an important technique for enhanced recovery after surgery (ERAS) because poorly controlled pain is associated with poor mobility, prolonged hospital stay, and increased complications. As in this study the surgical course was uneventful, all invasive monitoring lines like the CVP catheter and the arterial catheter were removed, and patients were allowed oral intake on POD 1. Patients were allowed to ambulate with support on POD 2 and without support on POD 3. Depending on the coagulation status, the epidural catheter was removed on PODs 3 or 4. IV antibiotics were stopped on POD 4. Patients were discharged on POD 5 or 6. TEA is recommended as a part of the ERAS programs following major abdominal surgery because it provides superior dynamic analgesia as compared with opiate PCA, (44) enables earlier return of gut function, (45) and is not an impediment to early mobilization provided hypotension and fluids shifts are managed appropriately. (46) Although several studies have been published regarding the ERAS program of hepatic resection, the optimal duration of epidural analgesia has not been standardized. (47) TEA is considered by many to be the reference standard for postoperative analgesia.
Until a better alternative is found, living donors should not be deprived the benefit of TEA and fear of the remote possibility of occurrence of any rare complication should not be a deterrent to its use. However, proper expertise in the epidural catheter placement at the appropriate level and removal of the catheter after the correction of coagulopathy should be strictly adhered to.
